Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers : Therapeutic effectiveness of COVID-19 convalescent plasma produced by HEMOPE: a multicenter, randomized and controlled clinical trial - PLAVID-TRIAL: Covid convalescent plasma - Clinical Trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Diabetes Mellitus; Hypertension; Lung Diseases; Respiratory Insufficiency; Respiration, Artificial; Critical Care; Hospitalization;C18.452.394.750;C14.907.489;C08.381;C08.618.846;E02.041.625;E02.760.190;E02.760.400
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-06-2020, Last updated: 2023-06-05

ICTRP ID:

RBR-7jqpnw

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO00433471X